triamcinolone acetonide has been researched along with Cochlear Hearing Loss in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JY; Nguyen, TN; Park, JS; Son, HY; Tangchang, W; Yoo, SY | 1 |
| Andrianakis, A; Graupp, M; Holzmeister, C; Kiss, P; Moser, U; Tomazic, PV; Wolf, A | 1 |
| Arnoldner, C; Auinger, A; Dahm, V; Honeder, C; Kaider, A; Nieratschker, M; Riss, D | 1 |
3 other study(ies) available for triamcinolone acetonide and Cochlear Hearing Loss
| Article | Year |
|---|---|
Sustained delivery of triamcinolone acetonide from a thermosensitive microemulsion gel system for the treatment of sensorineural hearing loss.
Topics: Animals; Emulsions; Hearing Loss, Sensorineural; Hydrogels; Mice; NIH 3T3 Cells; Surface-Active Agents; Triamcinolone Acetonide | 2023 |
Intratympanic Triamcinolone Acetonide as a Salvage Treatment for Idiopathic Sudden Sensorineural Hearing Loss.
Topics: Audiometry, Pure-Tone; Dexamethasone; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Injection, Intratympanic; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triamcinolone Acetonide | 2021 |
Intratympanic Triamcinolone Acetonide as Treatment Option for Idiopathic Sudden Sensorineural Hearing Loss.
Topics: Adult; Aged; Anti-Inflammatory Agents; Audiometry; Dexamethasone; Female; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Injection, Intratympanic; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide | 2019 |